Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
MonamiMVitaleVAmbrosioMLBartoliNToffanelloGRagghiantiBet al
So far, the Food and Drug Administration (FDA) has said they can be used to treat sleep apneaopens in a new tab and serious heart problemsopens in a new tab
The impact of glucagon-like peptide 1 receptor agonists on bone metabolism and its possible mechanisms in osteoporosis treatment
Transitioning Medicare coverage of GLP-1s for obesity from the mandatory Medicare GLP-1 Bridge to the voluntary BALANCE model sets up the possibility that beneficiaries with coverage under the short-term program may need to switch Part D plans during the 2027 open enrollment period, with potential cost and coverage implications for other medications they use.
US$ 22.88
US$ 24.60
US$ 25.04
US$ 21.68
US$ 29.67
US$ 24.65
US$ 20.36
US$ 27.50
US$ 22.52
